Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02907411 · ClinicalTrials.gov registry record · NA
Quadrivas Therapy® to Reduce Lipedema Subcutaneous Adipose Tissue (QUADRIVAS)
A NA study, sponsored by University of Arizona.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT02907411 is a NA study that has completed, run by University of Arizona. The registered enrollment target is 7 participants.
The verdict
NCT02907411, a NA study, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
Quad Rivas Therapy has been developed by Alyna Eekma from the Netherlands for over thirteen years; anecdotally she has been able to significantly reduce lipedema SAT in women with Stage 1 and 2 lipedema, and can reduce lipedema SAT by 80% in women with Stage 3 lipedema. The study will last for one month, for a total of 12 treatments per subject, seven subjects total, to see if there is a change in percent body fat percentage over the course of these treatments.
Interventions
- OTHER Quadrivas Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2016-09-01 |
| Est. Completion | 2017-03-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02907411
The ClinicalTrials.gov registry entry for NCT02907411 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Quadrivas Therapy is the first listed.
NCT02907411 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02907411 about?
NCT02907411 is a clinical study titled "Quadrivas Therapy® to Reduce Lipedema Subcutaneous Adipose Tissue (QUADRIVAS)". Quad Rivas Therapy has been developed by Alyna Eekma from the Netherlands for over thirteen years; anecdotally she has been able to significantly reduce lipedema SAT in women with Stage 1 and 2 lipedema, and can reduce lipedema SAT by 80% in women with Stage 3 lipedema. The study will last for one m...
What is the current status of trial NCT02907411?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2016-09-01. Estimated completion is 2017-03-18.
What interventions are being tested in trial NCT02907411?
The interventions under investigation include: Quadrivas Therapy (OTHER).
Who is sponsoring clinical trial NCT02907411?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.